Stocks and Investing Stocks and Investing
Fri, March 17, 2023
Thu, March 16, 2023

Koichi Mamegano Upgraded (TAK) to Strong Buy and Held Target at $20 on, Mar 16th, 2023


Published on 2024-10-28 02:18:12 - WOPRAI, Koichi Mamegano
  Print publication without navigation


Koichi Mamegano of B of A Securities, Upgraded "Takeda Pharmaceutical Company Limited" (TAK) to Strong Buy and Held Target at $20 on, Mar 16th, 2023.

Koichi, nor any peers, have made any analyst calls on TAK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources